Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

AstraZeneca - Evolving strategies: Managing treatment of early stage and advanced lung cancers

Locally advanced or metastatic EGFRm NSCLC: Targeted treatment options to improve outcomes in the first-line setting and beyond progression

Date

22 Sep 2020

Session

AstraZeneca - Evolving strategies: Managing treatment of early stage and advanced lung cancers

Presenters

David Planchard

Authors

D. Planchard

Author affiliations

  • Institut Gustave Roussy, 94800 - Villejuif/FR
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings